MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
2014 · Nature · 525 citations
https://doi.org/10.1038/nature13181
J
Jonas A. Nilsson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
274
Papers
11.2K
Citations
45
h-index
89
i10-index
Jonas A. Nilsson is an academic researcher from The University of Western Australia. The author has contributed to research in topics: Immunotherapy and Immune Responses & Ocular Oncology and Treatments & Cancer Immunotherapy and Biomarkers. The author has an h-index of 45, co-authored 233 publications.
ORCID: 0000-0003-0346-6837Papers by this author
worksThe PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
2021 · Nature Communications · 170 citations
https://doi.org/10.1038/s41467-021-25332-w
Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model
2017 · Nature Communications · 165 citations
https://doi.org/10.1038/s41467-017-00786-z
HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy–Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice
2019 · Cancer Research · 127 citations
https://doi.org/10.1158/0008-5472.can-18-3158
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study
2019 · BMC Cancer · 72 citations
https://doi.org/10.1186/s12885-019-5623-3
The Novel ETS Factor TEL2 Cooperates with Myc in B Lymphomagenesis
2005 · Molecular and Cellular Biology · 45 citations
https://doi.org/10.1128/mcb.25.6.2395-2405.2005
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat